Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDKRB2 | P30411 | 20/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7981624 | 1.00 | BDKRB2 (0.68) | BDKRB2 | |
| SCHEMBL7977168 | 0.93 | BDKRB2 (0.72) | BDKRB2 | |
| SCHEMBL7977171 | 0.93 | BDKRB2 (0.72) | BDKRB2 | |
| SCHEMBL7975770 | 0.91 | BDKRB2 (0.73) | BDKRB2 | |
| SCHEMBL7975767 | 0.91 | BDKRB2 (0.73) | BDKRB2 | |
| SCHEMBL6958321 | 0.89 | BDKRB2 (0.79) | BDKRB2 | |
| SCHEMBL6958328 | 0.89 | BDKRB2 (0.79) | BDKRB2 | |
| SCHEMBL8364253 | 0.81 | BDKRB2 (0.83) | BDKRB2 | |
| SCHEMBL8364252 | 0.81 | BDKRB2 (0.83) | BDKRB2 | |
| Fr-173657 SCHEMBL1559539 | 0.81 | BDKRB2 (1.00) | BDKRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6194396-B1 | ANTIALLERGENS; ANTIINFLAMMATION AGENTS; AUTOIMMUNE DISEASE; ANTISHOCK AGENTS; ANALGESICS; E.G., A 4 OR 7-PHENYLALKYLENE-OXYBENZIMIDAZOLE UNSUBSTITUTED OR SUBSTITUTED IN THE 1,2,3-POSITION WITH AN OXY, AMINO AND/OR THIO GROUP | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-02-27 | — | — | US | disclosed |
| US-6083961-A | FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-07-04 | — | — | US | disclosed |
| EP-0774462-A1 | HETEROCYCLIC COMPOUND | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-05-21 | — | — | EP | disclosed |